vimarsana.com

Latest Breaking News On - British columbia registered - Page 19 : vimarsana.com

BioVaxys Announces Appointment of Policy Advisor

BioVaxys Announces Appointment of Policy Advisor USA - English Share this article VANCOUVER, BC, May 20, 2021 /PRNewswire/  BioVaxys Technology Corp. (CSE: BIOV) (FRA:5LB) (OTC:BVAXF) ( BioVaxys ), a biotechnology company that is advancing viral and oncology vaccine platforms as well as immuno-diagnostic products, today announced the appointment of Adam Coutts, PhD, as Policy Advisor.   Dr. Coutts is a Senior Research Fellow at Magdalene College, University of Cambridge and a Research Associate in the Department of Sociology, University of Cambridge. Dr. Coutts research focuses on the social and political determinants of health looking at how non-health sector public policies affect the health and wellbeing of vulnerable groups and how government interventions can be used to help them. Dr. Coutts holds a PhD from the Department of Sociology, University of Cambridge and has held post-doctoral fellowships at Cambridge, and the Department of Politics and Internation

BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH Diagnostic

BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic

BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH Diagnostic USA - English News provided by Share this article Share this article VANCOUVER, B.C., April 29, 2021 /PRNewswire/ BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: BVAXF) ( BioVaxys or the Company ), the world leader in haptenized antigen vaccines for antiviral and cancer applications, announced today that it has filed with the United States Patent & Trademark Office ( USPTO ) an intent-to-use application to register the mark CoviDTH®, it s novel disposable T-cell immune response diagnostic for SARS-CoV-2.  BioVaxys President and CEO Kenneth Kovan commented As we get closer to market, we needed to register a trademark that would be descriptive, memorable, and defendable.  CoviDTH® is an ideal mark as it combines the letters DTH, or delayed type hypersensitivity, the mechanism behind our T-cell immune response diagnostic, with Covid-19.

BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic

BioVaxys Broadens Intellectual Property Portfolio Commercial Trademark Application Filed for CoviDTH® Diagnostic
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.